The triple blend adds the glycine component for patients who want comprehensive coverage of all three GLP-1 therapy concerns: efficacy, tolerability, and body composition
Polydextrose (fibres), L-carnitine tartrate, glucose, calcium lactate, magnesium lactate, red orange powder 6% (maltodextrin, red orange juice), flavour, choline bitartrate, ferrous sulphate, zinc lactate, colouring beetroot juice, acidulant citric acid, colour beta-carotene, sweetener sucralose
Each works differently
BPC-157 is considered a research peptide and is not approved as a pharmaceutical treatment for medical conditions
The disease later progresses to a latent phase with less symptoms and ultimately into a chronic or obstructive phase months to years later